Fractyl Health, Inc. will spend about $2 million to cut jobs and close some operations.

Oct 22, 2026, 7:10 AM ETTroubleRead the original at SEC EDGAR

Bad for GUTS

Fractyl Health plans to cut about 45% of its workforce, stop developing Rejuva internally, and pay about $2 million in severance costs, with more costs possible. Its Revita focus and the CEO taking on the president role offer continuity, but do not outweigh the deep cuts and lost program.

GUTS · Fractyl Health, Inc.

AI read · Bad for GUTS

The AI's read

This leaves Fractyl relying more on Revita, with fewer staff and no longer developing Rejuva itself. The company expects $2 million in severance costs and says other charges may arise. The CEO will also become president, and the departing executive is expected to advise the team. Those steps offer continuity, but do not replace the program being dropped or the deep staff cuts.

Get alerts for GUTS

Follow Fractyl Health, Inc. (GUTS) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for GUTS

Free on the App Store and Google Play, or on the web.